MA38905A1 - Compose stimulant le collagement et l'elastine et compositions topoques comprenant un tel compose - Google Patents

Compose stimulant le collagement et l'elastine et compositions topoques comprenant un tel compose

Info

Publication number
MA38905A1
MA38905A1 MA38905A MA38905A MA38905A1 MA 38905 A1 MA38905 A1 MA 38905A1 MA 38905 A MA38905 A MA 38905A MA 38905 A MA38905 A MA 38905A MA 38905 A1 MA38905 A1 MA 38905A1
Authority
MA
Morocco
Prior art keywords
compound
topo
elastin
collation
compose
Prior art date
Application number
MA38905A
Other languages
English (en)
Other versions
MA38905B1 (fr
Inventor
Tilborg Reiner Van
Original Assignee
Joventis S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49253380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA38905(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Joventis S A filed Critical Joventis S A
Publication of MA38905A1 publication Critical patent/MA38905A1/fr
Publication of MA38905B1 publication Critical patent/MA38905B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/39—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing seven carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un composé bicyclique de formule (i) et une composition pour un usage cosmétique et thérapeutique ainsi qu'une composition comprenant un véhicule acceptable et une quantité efficace du composé de formule (i).
MA38905A 2013-09-11 2014-09-11 Compose stimulant le collagement et l'elastine et compositions topoques comprenant un tel compose MA38905B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU92277A LU92277B1 (fr) 2013-09-11 2013-09-11 Composé cosmétique
PCT/EP2014/069424 WO2015036498A1 (fr) 2013-09-11 2014-09-11 Composé stimulant le collagène et l'élastine et compositions topiques comprenant un tel composé

Publications (2)

Publication Number Publication Date
MA38905A1 true MA38905A1 (fr) 2017-11-30
MA38905B1 MA38905B1 (fr) 2018-09-28

Family

ID=49253380

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38905A MA38905B1 (fr) 2013-09-11 2014-09-11 Compose stimulant le collagement et l'elastine et compositions topoques comprenant un tel compose

Country Status (33)

Country Link
US (1) US10426741B2 (fr)
EP (1) EP3044195B1 (fr)
JP (1) JP6693878B2 (fr)
KR (1) KR102080966B1 (fr)
CN (1) CN105683138A (fr)
AU (1) AU2014320342B2 (fr)
BR (1) BR112016005532B1 (fr)
CA (1) CA2924170C (fr)
CL (1) CL2016000561A1 (fr)
CY (1) CY1124142T1 (fr)
DK (1) DK3044195T3 (fr)
EA (1) EA033121B1 (fr)
ES (1) ES2869898T3 (fr)
HR (1) HRP20210717T1 (fr)
HU (1) HUE054445T2 (fr)
IL (1) IL244543B (fr)
LT (1) LT3044195T (fr)
LU (1) LU92277B1 (fr)
MA (1) MA38905B1 (fr)
MX (1) MX2016003257A (fr)
MY (1) MY173634A (fr)
NZ (1) NZ717696A (fr)
PE (1) PE20170293A1 (fr)
PH (1) PH12016500460A1 (fr)
PL (1) PL3044195T3 (fr)
PT (1) PT3044195T (fr)
RS (1) RS61792B1 (fr)
SG (1) SG11201601729PA (fr)
SI (1) SI3044195T1 (fr)
TN (1) TN2016000097A1 (fr)
UA (1) UA119752C2 (fr)
WO (1) WO2015036498A1 (fr)
ZA (1) ZA201602266B (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE285092C (fr)
DD285092A5 (de) * 1989-06-22 1990-12-05 Veb Chemische Werke Buna,Dd Verfahren zur erhoehung der selektivitaet der friedel-crafts-alkylierung von aromaten mit 1,2-dihalogenalkanen
EP0861260A1 (fr) 1995-11-15 1998-09-02 The Picower Institute For Medical Research Procede et agents ameliores de prevention du vieillissement des proteines
AU5997801A (en) 2000-05-15 2001-11-26 Canadian Inovatech, Inc. Compositions for the preservation of collagen and elastin
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
US10434049B2 (en) * 2013-09-11 2019-10-08 Joventis, S.A. Methods of producing compounds that stimulate hair regrowth, topical formulations, and methods of use

Also Published As

Publication number Publication date
CA2924170A1 (fr) 2015-03-19
KR20160054548A (ko) 2016-05-16
EP3044195A1 (fr) 2016-07-20
CN105683138A (zh) 2016-06-15
ES2869898T3 (es) 2021-10-26
EA201690527A1 (ru) 2016-07-29
AU2014320342B2 (en) 2018-05-31
LU92277B1 (fr) 2015-03-12
NZ717696A (en) 2019-12-20
BR112016005532B1 (pt) 2020-12-15
PL3044195T3 (pl) 2021-08-16
HUE054445T2 (hu) 2021-09-28
IL244543B (en) 2019-11-28
MY173634A (en) 2020-02-12
DK3044195T3 (da) 2021-05-03
IL244543A0 (en) 2016-04-21
AU2014320342A1 (en) 2016-03-24
CA2924170C (fr) 2020-05-12
MA38905B1 (fr) 2018-09-28
PE20170293A1 (es) 2017-03-19
US20160213623A1 (en) 2016-07-28
PH12016500460B1 (en) 2016-05-16
ZA201602266B (en) 2017-09-27
KR102080966B1 (ko) 2020-02-24
JP2016536340A (ja) 2016-11-24
WO2015036498A1 (fr) 2015-03-19
TN2016000097A1 (en) 2017-07-05
PT3044195T (pt) 2021-04-28
CL2016000561A1 (es) 2017-02-24
RS61792B1 (sr) 2021-06-30
JP6693878B2 (ja) 2020-05-13
UA119752C2 (uk) 2019-08-12
HRP20210717T1 (hr) 2021-06-11
EP3044195B1 (fr) 2021-02-17
EA033121B1 (ru) 2019-08-30
PH12016500460A1 (en) 2016-05-16
US10426741B2 (en) 2019-10-01
CY1124142T1 (el) 2022-05-27
SI3044195T1 (sl) 2021-08-31
LT3044195T (lt) 2021-05-25
MX2016003257A (es) 2016-07-26
SG11201601729PA (en) 2016-04-28

Similar Documents

Publication Publication Date Title
EA201500653A1 (ru) Композиции, содержащие триазольное соединение
MA42164A1 (fr) Composes biheteroaryle et leurs utilisations
MY148657A (en) Trpv1 antagonists and uses thereof
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
MA39034A1 (fr) Composés de quinoline sélectivement substitués
MA37519B1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
IN2014CN02515A (fr)
MA38039A1 (fr) Composés de céphem substitués en position 2
IN2014MN01640A (fr)
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
PH12014501784A1 (en) Substituted prolines / piperidines as orexin receptor antagonists
MA43409B1 (fr) Composés polycycliques à utiliser en tant qu'inhibiteurs de la tyrosine kinase de bruton
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
BR112015009649A2 (pt) composto de triazolo
GEP201606598B (en) Heteroaromatic compounds as dopamine d1 ligands
MA39152B1 (fr) Cyclopentanes substitués en 1,2 utilisés comme antagonistes du récepteur d'orexine
MA38884A1 (fr) Composé de triazolopyridine, compositions et procédés d'utilisation associés
MA37501B1 (fr) Composés de pyrazole utilisés en tant qu'inhibiteurs de sglt1
MX2015011536A (es) Nuevos antagonistas de receptores trpa1 de sulfamidas.
MA20150279A1 (fr) (r)-nifuratel, son utilisation pour le traitement d'infections et synthèse de (r) et (s)-nifuratel
SG10201907291QA (en) Monomethylfumarate prodrug compositions
PH12016500735A1 (en) Substituted pyrimidine compounds and their use as syk inhibitors
RS53002B (en) ANTI-CANCER UNIT AND PHARMACEUTICAL COPMOSITION CONTAINING IT
MA20150280A2 (fr) Dérivés d'aryléthynyle
MA38905A1 (fr) Compose stimulant le collagement et l'elastine et compositions topoques comprenant un tel compose